New paradigm in drug action: Differentiated gain of function amongst IMiD® analogues binding the E3 ubiquitin ligase, CRL4CRBN

被引：0
|
作者：
Hansen, Joshua [1 ]
机构：
[1] Celgene, La Jolla, CA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2016年 / 252卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
248
引用
收藏
页数：1
相关论文
共 7 条
  • [1] IKZF1/3 and CRL4CRBN E3 Ubiquitin Ligase Mutations Associate with IMiD Resistance in Relapsed Multiple Myeloma
    Garcia, Santiago Barrio
    Da Via', Matteo
    Garitano-Trojaola, Andoni
    Ruiz-Heredia, Yanira
    Bittrich, Max
    Shi, ChangXin
    Zhu, Yuan
    Lehners, Nicola
    Mai, Elias K.
    Raab, Marc S.
    Sonneveld, Pieter
    Martinez, Joaquin
    Rosenwald, Andreas
    Braggio, Esteban
    Einsele, Hermann
    Stewart, A. Keith
    Kortum, K. Martin
    [J]. BLOOD, 2017, 130
  • [2] CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma
    Barankiewicz, Joanna
    Salomon-Perzynski, Aleksander
    Misiewicz-Krzeminska, Irena
    Lech-Maranda, Ewa
    [J]. CANCERS, 2022, 14 (18)
  • [3] IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma
    Barrio, Santiago
    Munawar, Umair
    Zhu, Yuan Xiao
    Giesen, Nicola
    Shi, Chang-Xin
    Da Via, Matteo
    Sanchez, Ricardo
    Bruins, Laura
    Demler, Theresa
    Mueller, Nicole
    Haertle, Larissa
    Garitano, Andoni
    Steinbrunn, Torsten
    Danhof, Sophia
    Cuenca, Isabel
    Barrio-Garcia, Clara
    Braggio, Esteban
    Rosenwald, Andreas
    Martinez-Lopez, Joaquin
    Rasche, Leo
    Raab, Marc S.
    Stewart, A. Keith
    Einsele, Hermann
    Stuehmer, Thorsten
    Kortuem, K. Martin
    [J]. HAEMATOLOGICA, 2020, 105 (05) : E237 - E241
  • [4] CDK4/6 inhibition triggers dissociation of MEIS2 from CRL4CRBN E3 ligase to induce interferon response and reprogram myeloma for IMiD vulnerability
    Huang, Xiangao
    Jayabalan, David
    Di Liberto, Maurizio
    Chen, Zhengming
    Schinzel, Anna
    Ely, Scott A.
    Rossi, Adriana
    Coleman, Morton
    Lane, Joseph M.
    Hahn, William C.
    Mark, Tomer M.
    Niesvizky, Ruben
    Chen-Kiang, Selina
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [5] Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide: insights into CRL4 inhibition by small molecules
    Fischer, E. S.
    Boehm, K.
    Thoma, N. H.
    [J]. FEBS JOURNAL, 2014, 281 : 248 - 249
  • [6] Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
    Gandhi, Anita K.
    Kang, Jian
    Havens, Courtney G.
    Conklin, Thomas
    Ning, Yuhong
    Wu, Lei
    Ito, Takumi
    Ando, Hideki
    Waldman, Michelle F.
    Thakurta, Anjan
    Klippel, Anke
    Handa, Hiroshi
    Daniel, Thomas O.
    Schafer, Peter H.
    Chopra, Rajesh
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (06) : 811 - 821
  • [7] The CRL4CRBN E3 Ubiquitin Ligase Modulator CC-220 Inhibits BAFF-Mediated Plasmablast Differentiation and Immunoglobulin Secretion from Class Switched CD27+IgD-Memory and Lupus-Associated CD27-IgD-Double Negative B-Cells
    Nakayama, Yumi
    Kosek, Jolanta
    Capone, Lori
    Schafer, Peter H.
    Ringheim, Garth
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
1